Previous 10 | Next 10 |
Are These 3 Biotech Penny Stocks Worth Adding To Your List? Biotech penny stocks are a constant source of excitement for investors of all types. In 2021, the pandemic has made investing in the biotech industry extremely popular. While this began as a focus on Covid-related companies, it...
Are These Biotech Penny Stocks Worth Watching Right Now? There’s a reason why biotech penny stocks have remained so popular among investors this year. And while Covid initially was the main cause for heightened investor interest, its lasting effect has helped to bring a slew of t...
Spectrum Pharmaceuticals SPPI -35% after FDA declines to approve ROLONTIS Dicerna Pharmaceuticals DRNA -28% slide despite pivotal nedosiran study hitting primary endpoint Zynga ZNGA -16% on Q2 earnings release Chembio Diagnostics CEMI -13% on Q2 earning...
Asensus Surgical, Inc. (ASXC) Q2 2021 Earnings Conference Call August 5, 2021 04:30 PM ET Company Participants Mark Klausner - Westwicke, Investor Relations Anthony Fernando - President & Chief Executive Officer Shameze Rampertab - Chief Financial Officer Conference Call Participants Pres...
Asensus Surgical (NYSE:ASXC): Q2 Non-GAAP EPS of -$0.05 beats by $0.01; GAAP EPS of -$0.06 in-line. Revenue of $1.1M (+66.7% Y/Y) misses by $0.53M. The Company had cash and cash equivalents and restricted cash of approximately $158.1M as of June 30, 2021. Upcoming 2021 Milestones: For the ful...
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the second quarter 2021. ...
Asensus Surgical (ASXC) shares surge more than 25% premarket after the company received FDA 510k clearance for 5 mm diameter articulating instruments, adding to the Senhance Surgical System technology platform.Articulating instruments offer better access to difficult-to-reach a...
Instrument platform expected to expand dexterity and add capability to Senhance ® Surgical System Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Per...
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing two new board membe...
3 Biotech Penny Stocks for Your August Watchlist Biotech penny stocks are some of the hottest stocks of the past year and a half. While many investors have been focusing on popular penny stocks like AMC stock and GME stock, biotech small-caps have quietly been making big gains. Ther...
News, Short Squeeze, Breakout and More Instantly...
Asensus Surgical Inc Com Company Name:
ASXC Stock Symbol:
NYSE Market:
Asensus Surgical Inc Com Website:
RESEARCH TRIANGLE PARK, N.C., July 24, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, announced that The Rocky Mountain Hospital for Children in Denver, Colorado, part of HCA Healthcare’s Health...
RESEARCH TRIANGLE PARK, N.C., July 23, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDAȁ...
RESEARCH TRIANGLE PARK, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient, announced that LKH-Universitätsklinikum Graz in Austria has entered into an agreement ...